Synapse Open Synapse
Biology

Sensible Biotechnologies Raises $47M to Expand Next-Generation Platform for mRNA Medicines

GEN · · 2 min read

Sensible Biotechnologies raised $47 million to scale VECTOR, its integrated platform pairing AI-enabled mRNA design with manufacturing of naturally modified mRNA in living cells, aiming to develop novel therapeutics beyond vaccines.

Latest from GEN